Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Otsuka's 2012 sales performance.


Otsuka refiles 'digital' medicine for mental illness

Otsuka refiles 'digital' medicine for mental illness Now, Otsuka is ready to seek US approval once again and should hear back from the US regulator in the fourth quarter of this year. ... The so-called 'digital medicine' consists of Otsuka's Abilify (aripiprazole) embedded with Proteus' ingestible sensor

Japanese pharma pulls no punches with post-Brexit UK

Japanese pharma pulls no punches with post-Brexit UK The level of investment on the pharmaceutical side is considerable. The Japanese Pharmaceutical Group (JPG), an association of nine drugmakers - Astellas, Chugai, Daiichi-Sankyo, Eisai, Kowa, Mitsubishi Tanabe, Otsuka, Shionogi and

Deal Watch March 2017

Deal Watch March 2017 Among the company acquisitions, Sartorius paid $320m in cash to acquire the cell-based assay company, Essen BioScience; Otsuka paid $100m in upfront payments and will pay up to $150m in ... 320. Neurovance. Otsuka. Acquisition. Portfolio, including

Lundbeck partners with IBM Watson on drug research

Lundbeck partners with IBM Watson on drug research The deal will also see it set up a new real world evidence platform

Deal Watch December 2016

Deal Watch December 2016 1, 000. Akebia (US). Otsuka (Japan). Licence (US). Vadadustat: oral hypoxia-inducible factor (HIF) stabiliser in phase III for anaemia of chronic kidney disease. ... 400. X-Chem (US). Taiho/ Otsuka (Japan). Discovery collaboration &licence. Access to DEX

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...